Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 278, Issue 5 41-5, 2000, Pages

  Kawachi, Shigeyuki ^a   Jennings, Stephen ^a   Panes, Julian ^b   Cockrell, Adam ^a   Laroux, F Stephen ^a   Gray, Laura ^a   Perry, Michael ^c   Van Der Heyde, Henry ^a   Balish, Edward ^d   Granger, D Neil ^a   Specian, Robert A ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Immunology; Inflammation; Leukocytes

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL LEVEL; COLON DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DESCENDING COLON; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 18244429498     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2000.278.5.g734     Document Type: Article

References (58)

1. Androlewicz MJ, Browning JL, and Ware CF. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem 267: 2542-2547, 1992.
2. Autenrieth IB, Bucheler N, Bohn E, Heinze G, and Horak I. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41: 793-800, 1997.
3. Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W, and Jacoby HI. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 280: 988-1000, 1997.
4. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, and Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020, 1996.
5. Binion DG, West GA, Ina K, Ziats NP, Emancipator SN, and Fiocchi C. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112: 1895-1907, 1997.
6. Binion DG, West GA, Volk EE, Drazba JA, Ziats NP, Petras RE, and Fiocchi C. Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet 352: 1742-1746, 1998.
7. Bregenholt S and Claesson MH. Increased intracellular Th1 cytokines in SCID mice with inflammatory bowel disease. Eur J Immunol 28: 379-389, 1998.
8. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR, Newman W, and Ringler DJ. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 151: 97-110, 1997.
9. Butcher EC and Picker LJ. Lymphocyte homing and homeostasis. Science 272: 60-66, 1996.
10. Butcher EC, Williams M, Youngman K, Rott L, and Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 72: 209-253, 1999.
11. Carlos TM and Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101, 1994.
12. Conner EM, Brand S, Davis JM, Laroux FS, Palombella VJ, Fuseler JW, Kang DY, Wolf RE, and Grisham MB. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther 282: 1615-1622, 1997.
13. Connor EM, Eppihimer MJ, Morise Z, Granger DN, and Grisham MB. Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation. J Leukoc Biol 65: 349-355, 1999.
14. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, and Rennick DM. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 161: 3143-3149, 1998.
15. Diamond MS, Staunton DE, Marlin SD, and Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65: 961-971, 1991.
16. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, and Owen MJ. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 150: 91-97, 1997.
17. Elson CO. In defense of mucosal surfaces. Regulation and manipulation of the mucosal immune system. Adv Exp Med Biol 412: 373-385, 1997.
18. Elson CO, Cong Y, Brandwein S, Weaver CT, McCabe RP, Mahler M, Sundberg JP, and Leiter EH. Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann NY Acad Sci 859: 85-95, 1998.
19. Eppihimer MJ and Granger DN. In vivo measurements of endothelial cell adhesion molecule expression. Methods Enzymol 301: 14-22, 1999.
20. Eppihimer MJ, Russell J, Anderson DC, Wolitzky BA, and Granger DN. Endothelial cell adhesion molecule expression in gene-targeted mice. Am J Physiol Heart Circ Physiol 273: H1903-H1908, 1997.
21. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
22. Foster CA. VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J Allergy Clin Immunol 98, Suppl: S270-S277, 1996.
23. Goldman M, Marchant A, and Schandene L. Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation. Ann NY Acad Sci 796: 282-293, 1996.
24. Grisham MB and Granger DN. Leukocyte-endothelial cell interactions in inflammatory bowel disease. In: Inflammatory Bowel Disease, edited by J Kirnser. Philadelphia: Saunders, 2000, p. 55-64.
25. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, and Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742, 1997.
26. Haraldsen G, Kvale D, Lien B, Farstad IN, and Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156: 2558-2565, 1996.
27. Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, and Granger DN. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158: 1825-1832, 1997.
28. Hesterberg PE, Winsor-Hines D, Briskin MJ, Soler-Ferran D, Merrill C, Mackay CR, Newman W, and Ringler DJ. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology 111: 1373-1380, 1996.
29. Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, and Axon AT. Adhesion molecules in inflammatory bowel disease. Gut 36: 724-730, 1995.
30. Koizumi M, King N, Lobb R, Benjamin C, and Podolsky DK. Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103: 840-847, 1992.
31. Kuhn R, Lohler J, Rennick D, Rajewsky K, and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
32. Lalani I, Bhol K, and Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity [Erratum, Ann Allergy Asthma Immunol 80: A6, 1998]. Ann Allergy Asthma Immunol 79: 469-483, 1997.
33. Leach MW, Davidson NJ, Fort MM, Powrie F, and Rennick DM. The role of IL-10 in inflammatory bowel disease: "of mice and men." Toxicol Pathol 27: 123-133, 1999.
34. MacKay F, Browning JL, Lawton P, Shah SA, Comiskey M, Bhan AK, Mizoguchi E, Terhorst C, and Simpson SJ. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 115: 1464-1475, 1998.
35. Malizia G, Calabrese A, Cottone M, Raimondo M, Trejdosiewicz LK, Smart CJ, Oliva L, and Pagliaro L. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 100: 150-159, 1991.
36. Mason D and Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 10: 649-655, 1998.
37. Nakamura S, Ohtani H, Watanabe Y, Fukushima K, Matsumoto T, Kitano A, Kobayashi K, and Nagura H. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab Invest 69: 77-85, 1993.
38. Neurath MF, Fuss I, Kelsall BL, Stuber E, and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. JExp Med 182: 1281-1290, 1995.
39. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, and Kollias G. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27: 1743-1750, 1997.
40. Nortamo P, Li R, Renkonen R, Timonen T, Prieto J, Patarroyo M, and Gahmberg CG. The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol 21: 2629-2632, 1991.
41. Oshitani N, Campbell A, Bloom S, Kitano A, Kobayashi K, and Jewell DP. Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. Scand J Gastroenterol 30: 915-920, 1995.
42. Picarella D, Hurlbut P, Rottman J, Shi X, Butcher E, and Ringler DJ. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of SCID mice reconstituted with CD45RBhigh CD4+ T cells. J Immunol 158: 2099-2106, 1997.
43. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3: 171-174, 1995.
44. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, and Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553-562, 1994.
45. Powrie F, Mauze S, and Coffman RL. CD4+ T-cells in the regulation of inflammatory responses in the intestine. Res Immunol 148: 576-581, 1997.
46. Rennick D, Berg D, and Holland G. Interleukin 10: an overview. Prog Growth Factor Res. 4: 207-227, 1992.
47. Rennick D, Davidson N, and Berg D. Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol 76, Suppl: S174-S178, 1995.
48. -/- mice: an overview. J Leukoc Biol 61: 389-396, 1997.
49. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261, 1993.
50. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 148: 567-576, 1997.
51. Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J, Grenther WB, Balish E, Horak I, and Sartor RB. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 276: G1461-G1472, 1999.
52. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, and Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231, 1998.
53. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
54. Strober W, Fuss IJ, Ehrhardt RO, Neurath M, Boirivant M, and Ludviksson BR. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol 48: 453-458, 1998.
55. Strober W, Ludviksson BR, and Fuss IJ. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128: 848-856, 1998.
56. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, and Hammer RE. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180: 2359-2364, 1994.
57. Viney JL, Jones S, Chiu HH, Lagrimas B, Renz ME, Presta LG, Jackson D, Hillan KJ, Lew S, and Fong S. Mucosal addressin cell adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motif. J Immunol 157: 2488-2497, 1996.
58. Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, and Shanahan WR Jr. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 114: 1133-1142, 1998.